Fabrizio Landi

Toscana Life Sciences – Born in Siena in 1953. Graduated in bioengineering at the Milan Polytechnic. After an experience at a Bayer Group company, he started with others the Strategic Plan for the Ansaldo biomedical project, later become Esaote. He has been one of the members of the management since the company start and, from 2006, the Esaote’s CEO, supporting the growth of the company from scratches up to Sales of more than 340 Mio€. In January 2013 he left Esaote to pursue other personal initiatives. Presently he is an independent member of the Board of Directors of three Menarini companies, the major Italian Life Sciences Group. Since April 2012 he has been member of the Board of the CRF Bank, part of Intesa Sanpaolo Group, up to February 2019 when CRF Bank has been merged in Intesa Sanpaolo. Since May 2014 and up to May 2020, he has been member of the Board of Directors of Leonardo/Finmeccanica, the major Italian Aerospace& Defence Group. Since May 2014 he has been President of Toscana Life Science (TLS) Foundation, a Life Sciences accelerator/incubator, Healthcare technology promoter and Research institute based in Siena. In 2015 he co-founded Panakes Partners SGR, an investment company focused to Life Sciences Venture Capital activities: at Panakes he currently serves as President and Managing Partner and manages Funds, dedicated to Biotech, Medtech and healthcare IT, investing all over Europe since 2016. As Panakes related duties, he has also Board membership and Chairman positions in some portfolio companies of the SGR.